GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telescope Innovations Corp (OTCPK:TELIF) » Definitions » Cash-to-Debt

TELIF (Telescope Innovations) Cash-to-Debt : 0.19 (As of May. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Telescope Innovations Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Telescope Innovations's cash to debt ratio for the quarter that ended in May. 2024 was 0.19.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Telescope Innovations couldn't pay off its debt using the cash in hand for the quarter that ended in May. 2024.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Telescope Innovations's Cash-to-Debt or its related term are showing as below:

TELIF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.07   Med: No Debt   Max: No Debt
Current: 0.19

During the past 5 years, Telescope Innovations's highest Cash to Debt Ratio was No Debt. The lowest was 0.07. And the median was No Debt.

TELIF's Cash-to-Debt is ranked worse than
91.59% of 1487 companies
in the Biotechnology industry
Industry Median: 6.38 vs TELIF: 0.19

Telescope Innovations Cash-to-Debt Historical Data

The historical data trend for Telescope Innovations's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Telescope Innovations Cash-to-Debt Chart

Telescope Innovations Annual Data
Trend Dec19 Dec20 Aug21 Aug22 Aug23
Cash-to-Debt
0.29 0.09 No Debt No Debt No Debt

Telescope Innovations Quarterly Data
Sep19 Dec19 Mar20 Sep20 Dec20 Mar21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt 0.22 0.24 0.19

Competitive Comparison of Telescope Innovations's Cash-to-Debt

For the Biotechnology subindustry, Telescope Innovations's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Telescope Innovations's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telescope Innovations's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Telescope Innovations's Cash-to-Debt falls into.


Telescope Innovations Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Telescope Innovations's Cash to Debt Ratio for the fiscal year that ended in Aug. 2023 is calculated as:

Telescope Innovations had no debt (1).

Telescope Innovations's Cash to Debt Ratio for the quarter that ended in May. 2024 is calculated as:

Cash to Debt Ratio= Cash, Cash Equivalents, Marketable Securities / Total Debt
= Cash, Cash Equivalents, Marketable Securities / (Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation)
=0.274 / (0.066 + 1.414)
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telescope Innovations  (OTCPK:TELIF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Telescope Innovations Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Telescope Innovations's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Telescope Innovations Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telescope Innovations Corp (OTCPK:TELIF) » Definitions » Cash-to-Debt
Comparable Companies
TSXV:QPT TSX:AEZS XCNQ:BLAB XCNQ:ASEP XCNQ:MDMA XCNQ:PHRM XCNQ:COOL TSXV:KNE NEOE:AWKN XCNQ:BETR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
TELI:Canada
Address
301 – 2386 East Mall, Vancouver, BC, CAN, V6T 1Z3
Website
https://www.telescopeinnovations.com
Telescope Innovations Corp is a technology company that intends to focus on development as a Contract Research Organization (CRO) to develop intellectual property, contract research, and building automation products. The Company has one operating segment that generates revenues from two revenue streams, contract research services and sale of automation products.